Apodi Limited’s Post

Disparities across NHS Trusts are vast! 🚨 Factors such as access to resources, patient demographics, and care pathways all contribute to this issue - but what is the solution? 🤔 Market Research plays a crucial role in uncovering these disparities and tailoring solutions to meet local needs. 🔍 At Apodi, we routinely deploy Insight SPRINT programmes, which conduct market research, to assess local market conditions across regions and specialities. 📊 Learn more about our approach here 👉https://lnkd.in/eUfC45UB #Healthcare #Pharmaceuticals #MarketResearch #PatientSafety #PatientCare #PatientCentricity #NHS

Boost your Phase II trial advancement with TrialKey. Our platform evaluates drug effectiveness, predicts endpoints, and targets the right demographics. Utilising real-world data from 350,000 trials and competitor analysis, we ensure your trials meet efficacy and safety benchmarks. Phase II Trials test Efficacy & Side Effects On average, 33% succeed TrialKey can be used in ways such as selecting optimal number of sites, what countries, which sites, what CRO’s to work with based on previous successes with that condition, predicts probability of meeting end points, endpoints, identifying inclusion/exclusion criteria, and more! Book a demo today: https://appt.link/minhthu #clinicaltrials #ai #medicalresearch #trialkey #drugdiscovery #healthtech 

Patient demographics refer to the statistical characteristics of a patient population. These characteristics include factors such as age, gender, race, ethnicity, income level, education, occupation, geographic location, and sometimes other factors like marital status, insurance coverage, and health status. Patient demographics are crucial for pharmaceutical companies because they enable targeted marketing, ensuring that resources are effectively allocated and messages resonate with specific groups. Understanding demographics guides product development by identifying unmet needs and ensuring clinical trials are representative.Demographics help optimize sales strategies by predicting demand and deploying sales forces where they are most needed. Additionally, they aid in market expansion by identifying new opportunities and adapting strategies to local cultures. Pharmaceutical companies use various methods to measure and analyze patient demographics as part of their marketing strategies. #patient #demography #strategy #pharma #pharmaceutical #branding #clinicaltrial #EHR #data #healthcare #innovation #startup #pharmacy #insurance #sales #salesforce #survey #marketresearch

Hospitals must assess their competitive environment, contracted payers, and patient demographics to conduct an effective CDM Review and Contract Analysis. Armed with this information, you can identify areas of risk and opportunity and prioritize your efforts accordingly.  A comprehensive analysis should include data sampling, forensic analysis of paid and denied claims, and an evaluation of net revenue by payer, product, and volume. Learn more about seven key elements of a defensible pricing strategy for hospitals in our last newsletter https://lnkd.in/g-rzTH8v #healthcareconsulting #linkedinnewsletter #CDM #medicalpractice #physicians

Unlock the power of patient segmentation to deliver personalized communications that truly resonate. By categorizing patients based on demographics like age, gender, location, medical history, and more, you can develop tailored strategies and messages for each specific segment. Thus, tailoring your approach with relevant content, from mammography guidelines for women to dietary advice for diabetes patients, ensures each interaction is impactful and meaningful. 💡 Why it matters? Personalization is crucial in healthcare. Many patients prefer it, and nearly half might switch providers without it. Effective segmentation not only retains but actively engages your patients. 👀 Curious about the potential benefits? Check out the latest statistics on patient preferences regarding personalized communication. #telemedicine  #patientengagement #patientsatisfaction #digitalhealth #telehealth

An effective CDM review and contract analysis is loaded with intricacies. It includes analyzing the competitive environment, contracted payers, patient demographics, and the list goes on! Once you have that information, you can identify areas of risk and opportunity and prioritize your efforts accordingly. Then comes the comprehensive analysis that should include data sampling, forensic analysis of paid and denied claims, and an evaluation of net revenue by payer, product, and volume. We speak to the seven key elements of a defensible pricing strategy for hospitals and practices in our last V2V Management Solutions newsletter https://lnkd.in/g-rzTH8v. If all of this sounds like too much paperwork, and you just want to practice medicine, feel free to send me a direct message, and we can discuss ways to lighten the load for you! #healthcareconsulting #linkedinnewsletter #CDM #medicalpractice #physicians

Friday Fuel 💜 Excited to share our quarterly publication on all things patient recruitment Get the full report: https://lnkd.in/gChZdZAQ Power is the fastest growing clinical trial finder on the internet! Inside you'll find: ✅ Insights from patients using Power ✅ The industry in numbers (recruiting trials by phase, therapeutic area, demographics etc.) ✅ Top 10 sites and sponsors by patient responsiveness ✅ Key industry news this quarter

How can we make clinical trials more inclusive? 🔬 With the recent publication of the FDA’s draft guidance on Diversity Action Plans (DAPs), the industry has taken significant steps toward ensuring that clinical trials accurately reflect the demographics of the populations using the medical products being tested. We collected everything you need to know about the FDA diversity draft guidance, so why not dive into some key aspects and implications below? 🔍 And, to grasp the full picture, read our recent article on the topic: https://lnkd.in/eSq_qCJs #FDA #diversity #clinicaltrials #blog

Scenario: Healthcare System for Monitoring Growth in Children Problem: The clinic wants to predict a child’s weight based on their height using historical data, in order to: -> Identify early signs of health issues, such as malnutrition or obesity. -> Provide personalized dietary recommendations. -> Set growth benchmarks for children of specific ages and demographics. Solution:  Linear Regression Using a Linear Regression Algorithm, the clinic can create a model where the input is the child's height, and the predicted output is the child's weight. Given historical data, the algorithm will learn the relationship between height and weight and can predict weight based on the height of a new patient. Check it out here: https://lnkd.in/gBfE4Wc4 Git: https://lnkd.in/gFwsf-UY Thanks

Question: PMCF studies can help identify ___ that were not apparent during pre-market clinical investigations. A. Long-term performance issues. B. New patient demographics. C. Manufacturing defects. D. Marketing opportunities. #MedicalDevices #PMCF #ClinicalResearch #MedicalInnovation #HealthcareQuality #PatientSafety #RegulatoryCompliance #LongTermPerformance #MedicalDeviceTesting #HealthcareResearch